Icecure Medical Ltd reports results for the quarter ended March 31 - Earnings Summary

Icecure Medical

28/05/2025 16:04

Icecure Medical Ltd ICCM.OQ reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -8 cents.  The mean expectation of two analysts for the quarter was for a loss of 8 cents per share.

Revenue fell 2.4% to $725.00 thousand from a year ago; analysts expected $750.00 thousand.

Icecure Medical Ltd's reported EPS for the quarter was a loss of 6 cents​.

The company reported a quarterly loss of $3.59 million.

Icecure Medical Ltd shares had fallen by 3.9% this quarter and gained 2.7% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 6.7% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Icecure Medical Ltd is $3.00

This summary was machine generated from LSEG data May 28 at 03:04 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.08
-0.06
Beat
Dec. 31 2024
-0.07
-0.08
Missed
Sep. 30 2024
-0.07
-0.08
Missed
Jun. 30 2024
-0.07
-0.06
Beat